Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response

Fig. 8

Proposed model for MAPK inhibition in paired TP53WT and TP53MUT cell lines selected for resistance to MDM2 inhibitors. WM35-R (a) and SN40R2 (b) were selected from WM35 and SJSA-1 respectively and both were sensitive to growth inhibition by MAPK pathway inhibition. The TP53MUT cells lost p53-dependent apoptosis but retained p53-independent cell cycle arrest and growth inhibition in response to inhibition of the MAPK pathway. SJSA-1 showed minimal p53-dependent apoptosis in response to MAPK pathway inhibition, plausibly resulting from p53 suppression by overexpression of MDM2

Back to article page